Replication and cumulative effects of GWAS-identified genetic variations for prostate cancer in Asians: A case-control study in the ChinaPCa consortium

Carcinogenesis

Volumn 33, Issue 2, 2012, Pages 356-360

  Wang, Meilin ^a,b,c   Liu, Fang ^d   Hsing, Ann W ^e   Wang, Xiang ^f   Shao, Qiang ^g   Qi, Jun ^h   Ye, Yu ⁱ   Wang, Zhong ^h   Chen, Hongyan ^d   Gao, Xin ^j   Wang, Guozeng ^k   Chu, Lisa W ^e   Ding, Qiang ^f   Ouyang, Jun ^l   Gao, Xu ^m   Huang, Yichen ^h   Chen, Yanbo ^h   Gao, Yu Tang ⁿ   Zhang, Zuo Feng ^o   Rao, Jiangyu ^p   Shi, Rong ^h   Wu, Qijun ^h   Zhang, Yuanyuan ^q   Jiang, Haowen ^f   Zheng, Jie ^f   Hu, Yanlin ^h   Guo, Ling ^r   Lin, Xiaoling ^d   Tao, Sha ^r   Jin, Guangfu ^q   Sun, Jielin ^d,q   Lu, Daru ^d   Zheng, S Lilly ^d,q   Sun, Yinghao ^m   Mo, Zengnan ⁱ   Yin, Changjun ^s   Zhang, Zhengdong ^a,b,c   Xu, Jianfeng ^d,f,q,r   more..

^a Nanjing Medical University   (China)

^b School of Public Health   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

^d FUDAN UNIVERSITY   (China)

^e NATIONAL CANCER INSTITUTE   (United States)

^f FUDAN UNIVERSITY   (China)

^g SUZHOU MUNICIPAL HOSPITAL   (China)

^h SHANGHAI JIAO TONG UNIVERSITY   (China)

ⁱ GUANGXI MEDICAL UNIVERSITY   (China)

^j SUN YAT SEN UNIVERSITY   (China)

^k Pudong Gongli Hospital   (China)

^l SOOCHOW UNIVERSITY   (China)

^m SECOND MILITARY MEDICAL UNIVERSITY   (China)

ⁿ SHANGHAI CANCER INSTITUTE   (China)

^o UNIVERSITY OF CALIFORNIA   (United States)

^p UNIVERSITY OF CALIFORNIA   (United States)

^q WAKE FOREST SCHOOL OF MEDICINE   (United States)

^r VAN ANDEL RESEARCH INSTITUTE   (United States)

^s THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

more..

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR C 6A; MESSENGER RNA; REGULATORY FACTOR X 6; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

AGED; ALLELE; ARTICLE; CANCER PATIENT; CANCER RISK; CASE CONTROL STUDY; CHINESE; CHROMOSOME 13Q; CHROMOSOME 2P; CHROMOSOME 5P; CHROMOSOME 6P; CHROMOSOME 6Q; CONTROLLED STUDY; DISEASE SEVERITY; FAMILY HISTORY; GENE EXPRESSION PROFILING; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84863011395     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgr279     Document Type: Article

References (27)

1. Jemal, A. et al. (2010) Cancer statistics. CA Cancer J. Clin., 60, 277-300.
2. Matsuda, T. et al. (2009) Comparison of time trends in prostate cancer incidence (1973-2002) in Asia, from cancer incidence in five continents, Vols IV-IX. Jpn. J. Clin. Oncol., 39, 468-469.
3. Jian, L. et al. (2004) Protective effect of green tea against prostate cancer: a case-control study in southeast China. Int. J. Cancer, 108, 130-135.
4. Gronberg, H. (2003) Prostate cancer epidemiology. Lancet, 361, 859-864.
5. Manolio, T.A. et al. (2008) A HapMap harvest of insights into the genetics of common disease. J. Clin. Invest., 118, 1590-1605.
6. Rahim, N.G. et al. (2008) Genetic determinants of phenotypic diversity in humans. Genome Biol., 9, 215.
7. Witte, J.S. (2009) Prostate cancer genomics: towards a new understanding. Nat. Rev. Genet., 10, 77-82.
8. Takata, R. et al. (2010) Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population. Nat. Genet., 42, 751-754.
9. Gudmundsson, J. et al. (2009) Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility. Nat. Genet., 41, 1122-1126.
10. Eeles, R.A. et al. (2009) Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. Nat. Genet., 41, 1116-1121.
11. Liu, F. et al. (2011) Systematic confirmation study of reported prostate cancer risk-associated single nucleotide polymorphisms in Chinese men. Cancer Sci., 102, 1916-1920.
12. Shao, P. et al. (2011) Functional polymorphisms in cell death pathway genes FAS and FAS ligand and risk of prostate cancer in a Chinese population. Prostate, 71, 1122-1130.
13. Xu, B. et al. (2010) A functional polymorphism in MSMB gene promoter is associated with prostate cancer risk and serum MSMB expression. Prostate, 70, 1146-1152.
14. Zheng, S.L. et al. (2010) Association of 17 prostate cancer susceptibility loci with prostate cancer risk in Chinese men. Prostate, 70, 425-432.
15. Barrett, J.C. et al. (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics, 21, 263-265.
16. Lee, W.C. et al. (2005) Data-dredging gene-dose analyses in association studies: biases and their corrections. Cancer Epidemiol. Biomarkers Prev., 14, 3004-3006.
17. Ghoussaini, M. et al. (2008) Multiple loci with different cancer specificities within the 8q24 gene desert. J. Natl Cancer Inst., 100, 962-966.
18. Aftab, S. et al. (2008) Identification and characterization of novel human tissue-specific RFX transcription factors. BMC Evol. Biol., 8, 226.
19. Smith, S.B. et al. (2010) Rfx6 directs islet formation and insulin production in mice and humans. Nature, 463, 775-780.
20. Pi, M. et al. (2005) Identification of a novel extracellular cation-sensing G-protein-coupled receptor. J. Biol. Chem., 280, 40201-40209.
21. Wellendorph, P. et al. (2004) Molecular cloning, expression, and sequence analysis of GPRC6A, a novel family C G-protein-coupled receptor. Gene, 335, 37-46.
22. Kuang, D. et al. (2005) Cloning and characterization of a family C orphan G-protein coupled receptor. J. Neurochem., 93, 383-391.
23. Pi, M. et al. (2008) GPRC6A null mice exhibit osteopenia, feminization and metabolic syndrome. PLoS One, 3, e3858.
24. Yamada, H. et al. (2009) Replication of prostate cancer risk loci in a Japanese case-control association study. J. Natl Cancer Inst., 101, 1330-1336.
25. Kader, A.K. et al. (2009) Individual and cumulative effect of prostate cancer risk-associated variants on clinicopathologic variables in 5,895 prostate cancer patients. Prostate, 69, 1195-1205.
26. Kote-Jarai, Z. et al. (2008) Multiple novel prostate cancer predisposition loci confirmed by an international study: the PRACTICAL Consortium. Cancer Epidemiol. Biomarkers Prev., 17, 2052-2061.
27. Gelmann, E.P. (2008) Complexities of prostate-cancer risk. N. Engl. J. Med., 358, 961-963.